View Author
study patient trial lp-pla disease heart event platelet lp-pla 2 activity /iiia death heart disease infarction activity gpiib inhibition angina treatment participant definition outcome stroke level data elements therapy element lp-pla 2 baseline lp-pla 2 mass gpiib /iiia inhibitors receptor group syndrome sibra placebo randomized history factor blood agent cholesterol mortality phospholipase inhibitor hospital result standard american college lipoprotein-associated phospholipase american plaque point platelet aggregation solid-timi 52 trial association risk factors circulation aggregation admission phase darapladib elevation committee medication artery pressure glycoprotein subject change registry aspirin diabetes webappendix evidence type 2 diabetes month effect value 24 hours bene fit
5 Most Recent Publications
|
Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome
(Article)
O'Donoghue, M.L. Braunwald, E. Cicconetti, G. Lukas, M.A. Tarka, E. Cannon, C.P. White, H.D. Serruys, P.W.J.C. Steg, P.G. Hochman, J.S. Maggioni, A.P. Bode, C. Weaver, W.D. Johnson, J.L. |
2011-10-01
|
|
Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies
(Article)
Thompson, A. Gao, P. Hofman, A. Packard, C. Collins, R. Danesh, J. Orfei, L. Watson, S. Angelantonio, E. di Kaptoge, S. Ballantyne, C. Cannon, C.P. Criqui, M. Cushman, M. |
2010-05-03
|
|
Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in diabetes patients with Cardiovascular History (APPROACH): Study design and baseline characteristics
(Article)
Ratner, R.E. Cannon, C.P. Gerstein, H.C. Nesto, R.W. Serruys, P.W.J.C. Es, G.A. van Kolatkar, N.S. Kravitz, B.G. Zalewski, A. Fitzgerald, P.J. |
2008-12-01
|
|
Oral glycoprotein IIb/IIIa receptor inhibitors in patients with cardiovascular disease: why were the results so unfavourable.
(Article)
Leebeek, F.W.G. Boersma, H. Cannon, C.P. Simoons, M.L. Werf, F.J.J. van de |
2002-03-01
|
|
American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes.
(Article)
Cannon, C.P. Battler, A. Werf, F.J.J. van de Weintraub, W.S. Brindis, R.G. Cox, J.L. Ellis, S.G. Every, N.R. Flaherty, J.T. Harrington, R.A. Krimholz, H.M. Simoons, M.L. |
2001-12-17
|
